Financhill
Back

Immunovant Stock Predictions

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 58% based on the past 4 years of stock performance.
  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $30.71. The Score for IMVT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 58% based on the past 4 years of stock performance.

Immunovant Stock Rating

Sell
40
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
14.11

Prediction Charts

Market Cap:
4.46B
Price in USD:
30.71
Volume:
718.68K
Beta:
0.70

Technical Analysis

SMA50:
33.84
SMA100:
36.76
SMA200:
31.61
52-Wk Change:
109.62%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 30.71 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-22 32.95 32.18 33.00 31.53
Mar-25 32.42 31.22 32.78 31.04
Mar-26 31.34 31.43 32.03 31.15
Mar-27 31.56 32.51 33.13 31.28
Mar-28 32.84 32.26 32.95 31.53
Apr-1 31.91 31.64 32.27 31.41
Apr-2 30.89 30.78 32.12 30.49
Apr-3 30.42 31.20 31.25 29.90
Apr-4 31.37 30.85 31.70 30.79
Apr-5 30.75 31.46 32.40 30.09
Apr-8 31.08 30.51 31.38 30.00
Apr-9 30.91 31.17 31.51 30.61
Apr-10 31.00 30.86 31.16 30.39
Apr-11 30.72 30.71 31.19 29.82

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.10 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.